News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Arndt Vogel: CHMP recommended a conditional marketing authorisation for zanidatamab for the treatment of HER2-positive biliary tract cancer
Arndt Vogel/X
Apr 27, 2025, 16:54

Arndt Vogel: CHMP recommended a conditional marketing authorisation for zanidatamab for the treatment of HER2-positive biliary tract cancer

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology at Hannover Medical School, shared a post on X:

“CHMP recommended a conditional marketing authorisation for zanidatamab for the treatment of HER2-positive biliary tract cancer
  • based on HERIZON-BTC: ORR 41%
  • Phs-III in 1st line ongoingArndt Vogel: CHMP recommended a conditional marketing authorisation for zanidatamab for the treatment of HER2-positive biliary tract cancer

More posts featuring biliary tract cancer.

Arndt Vogel Biliary tract cancer cancer OncoDaily Oncology Zanidatamab
Special Coverage
Blog
Apr 27, 2025, 16:54
Arndt Vogel: CHMP recommended a conditional marketing authorisation for zanidatamab for the treatment of HER2-positive biliary tract cancer
Blog
Apr 27, 2025, 16:50
Olubukola Ayodele's mission to transform cancer care systems
Blog
Apr 27, 2025, 16:49
Sanjay Popat: Great to be at LCS 2025 with great dynamic colleagues from Asia
Science
Apr 27, 2025, 16:40
New review on cancer survivorship care in Africa - NCI Center for Global Health
Blog
Apr 27, 2025, 16:29
Icro Meattini: Get ready for ESTRO 2025 - Download the app and attend sessions
Opinion
Apr 27, 2025, 16:28
Vivek Subbiah Highlights AACR Enduring Impact Award for Rick Pazdur
Positive
Apr 27, 2025, 16:27
Douglas Flora: The impact of community Lung Cancer Screening Program at St. Elizabeth Healthcare
Blog
Apr 27, 2025, 16:13
Luigi Lorini: Sharing my thoughts on crucial topics about HNSCC during the latest ESMO meeting in Barcelona
Blog
Apr 27, 2025, 16:07
Paolo Tarantino: List of dual-payload ADCs to be presented at AACR25
Oncolibrary
Apr 27, 2025, 16:02
Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab
Blog
Apr 27, 2025, 16:01
Sumanta K. Pal: Could not be more proud of Nick Salgia who gave a stellar thesis defense
Blog
Apr 27, 2025, 16:00
Amer Zeidan: Yale Cancer Center is looking for a junior clinical investigator to join the myeloma program